ICLR

ICONF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

ICLR vs peer average

15/100

ICLR vs. peer average (F vs. C)

Grade spread

A 3 · B 4 · C 1 · D 2 · F 2

Graded peers loaded

Coverage

12 graded

100% of tracked

Peer overview

IQV is the first available peer comparator.

IQVIA is a direct large-scale CRO competitor for global development programs; ICON's 2024 Form 20-F identifies IQVIA among the primary competitors for large development programs, making IQV a cleaner operating comp than drug-developer peers for backlog, bookings, pricing, and trial execution read-through [#20F-2024].

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerIQVIQVIA

ICLR

ICON

IQV

IQVIA

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs IQV

ICLR / IQV

Grade Position

Below peers

ICLR vs. peer average (F vs. C)

15/100

Momentum

IQV

Value

ICLR

Sentiment

IQV

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs ICLR

IQV

100/100

-4

FTRE

80/100

-3

MEDP

40/100

-1

TMO

80/100

-3

EXEL

Exelixis Inc Common

40/100

-1

IQV is the first peer returned for this comparison set.